Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BI 54903 XX and BHT in Healthy Volunteers
NCT02221375Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2008
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial of olodaterol in asthma (9 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of patients with adverse events, Number of patients with clinically significant findings in vitals signs and 4 more. Started Jun 2008; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02221375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221375.